vs
Side-by-side financial comparison of Stoke Therapeutics, Inc. (STOK) and Vital Farms, Inc. (VITL). Click either name above to swap in a different company.
Vital Farms, Inc. is the larger business by last-quarter revenue ($213.6M vs $158.6M, roughly 1.3× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 7.6%, a 63.5% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 28.7%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $-32.1M).
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
Vital Tomosi Dairy Limited is a dairy processing company in Uganda. The company is a joint venture between Vital Capital Fund, "an impact investing fund primarily focused on Sub-Saharan Africa", and "Tomosi Dairy Farms, a Ugandan producer of dairy products".
STOK vs VITL — Head-to-Head
Income Statement — Q1 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $158.6M | $213.6M |
| Net Profit | $112.9M | $16.3M |
| Gross Margin | — | 35.8% |
| Operating Margin | 70.2% | 10.0% |
| Net Margin | 71.2% | 7.6% |
| Revenue YoY | 3661.1% | 28.7% |
| Net Profit YoY | 528.0% | 54.3% |
| EPS (diluted) | $1.90 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $213.6M | ||
| Q3 25 | — | $198.9M | ||
| Q2 25 | — | $184.8M | ||
| Q1 25 | $158.6M | $162.2M | ||
| Q4 24 | $22.6M | $166.0M | ||
| Q3 24 | — | $145.0M | ||
| Q2 24 | — | $147.4M | ||
| Q1 24 | — | $147.9M |
| Q4 25 | — | $16.3M | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | — | $16.6M | ||
| Q1 25 | $112.9M | $16.9M | ||
| Q4 24 | $-10.5M | $10.6M | ||
| Q3 24 | — | $7.4M | ||
| Q2 24 | — | $16.3M | ||
| Q1 24 | — | $19.0M |
| Q4 25 | — | 35.8% | ||
| Q3 25 | — | 37.7% | ||
| Q2 25 | — | 38.9% | ||
| Q1 25 | — | 38.5% | ||
| Q4 24 | — | 36.1% | ||
| Q3 24 | — | 36.9% | ||
| Q2 24 | — | 39.1% | ||
| Q1 24 | — | 39.8% |
| Q4 25 | — | 10.0% | ||
| Q3 25 | — | 10.8% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | 70.2% | 13.4% | ||
| Q4 24 | -60.4% | 7.8% | ||
| Q3 24 | — | 6.4% | ||
| Q2 24 | — | 11.6% | ||
| Q1 24 | — | 16.3% |
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 8.3% | ||
| Q2 25 | — | 9.0% | ||
| Q1 25 | 71.2% | 10.4% | ||
| Q4 24 | -46.4% | 6.4% | ||
| Q3 24 | — | 5.1% | ||
| Q2 24 | — | 11.1% | ||
| Q1 24 | — | 12.9% |
| Q4 25 | — | $0.35 | ||
| Q3 25 | — | $0.36 | ||
| Q2 25 | — | $0.36 | ||
| Q1 25 | $1.90 | $0.37 | ||
| Q4 24 | $-0.15 | $0.23 | ||
| Q3 24 | — | $0.16 | ||
| Q2 24 | — | $0.36 | ||
| Q1 24 | — | $0.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $274.8M | $48.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $350.1M | $351.3M |
| Total Assets | $406.9M | $518.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $48.8M | ||
| Q3 25 | — | $93.8M | ||
| Q2 25 | — | $108.2M | ||
| Q1 25 | $274.8M | $156.3M | ||
| Q4 24 | $128.0M | $150.6M | ||
| Q3 24 | — | $149.5M | ||
| Q2 24 | — | $133.2M | ||
| Q1 24 | — | $113.8M |
| Q4 25 | — | $351.3M | ||
| Q3 25 | — | $331.2M | ||
| Q2 25 | — | $309.8M | ||
| Q1 25 | $350.1M | $288.9M | ||
| Q4 24 | $229.0M | $269.3M | ||
| Q3 24 | — | $253.4M | ||
| Q2 24 | — | $238.4M | ||
| Q1 24 | — | $213.3M |
| Q4 25 | — | $518.7M | ||
| Q3 25 | — | $481.5M | ||
| Q2 25 | — | $430.8M | ||
| Q1 25 | $406.9M | $376.9M | ||
| Q4 24 | $271.6M | $359.3M | ||
| Q3 24 | — | $344.7M | ||
| Q2 24 | — | $320.5M | ||
| Q1 24 | — | $300.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $131.8M | $5.8M |
| Free Cash FlowOCF − Capex | $131.7M | $-32.1M |
| FCF MarginFCF / Revenue | 83.0% | -15.1% |
| Capex IntensityCapex / Revenue | 0.1% | 17.8% |
| Cash ConversionOCF / Net Profit | 1.17× | 0.35× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-48.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.8M | ||
| Q3 25 | — | $23.4M | ||
| Q2 25 | — | $-761.0K | ||
| Q1 25 | $131.8M | $5.3M | ||
| Q4 24 | $-23.2M | $14.8M | ||
| Q3 24 | — | $10.0M | ||
| Q2 24 | — | $16.1M | ||
| Q1 24 | — | $23.9M |
| Q4 25 | — | $-32.1M | ||
| Q3 25 | — | $-10.6M | ||
| Q2 25 | — | $-7.6M | ||
| Q1 25 | $131.7M | $2.1M | ||
| Q4 24 | $-23.2M | $-3.4M | ||
| Q3 24 | — | $6.4M | ||
| Q2 24 | — | $10.5M | ||
| Q1 24 | — | $22.6M |
| Q4 25 | — | -15.1% | ||
| Q3 25 | — | -5.3% | ||
| Q2 25 | — | -4.1% | ||
| Q1 25 | 83.0% | 1.3% | ||
| Q4 24 | -102.7% | -2.0% | ||
| Q3 24 | — | 4.4% | ||
| Q2 24 | — | 7.2% | ||
| Q1 24 | — | 15.3% |
| Q4 25 | — | 17.8% | ||
| Q3 25 | — | 17.1% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | 0.1% | 1.9% | ||
| Q4 24 | 0.2% | 10.9% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 3.8% | ||
| Q1 24 | — | 0.9% |
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 1.43× | ||
| Q2 25 | — | -0.05× | ||
| Q1 25 | 1.17× | 0.31× | ||
| Q4 24 | — | 1.40× | ||
| Q3 24 | — | 1.34× | ||
| Q2 24 | — | 0.99× | ||
| Q1 24 | — | 1.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
STOK
Segment breakdown not available.
VITL
| Eggs And Egg Related Products | $205.8M | 96% |
| Butter And Butter Related Products | $7.7M | 4% |
